Medical research

Targeting mitochondria in pulmonary hypertension

Pulmonary Arterial Hypertension (PAH) is a debilitating disease of the lung blood vessels that causes heart failure and early death, affecting hundreds of thousands of patients worldwide. Available therapies fail to prolong ...

Attention deficit disorders

Air pollution and poverty stack the deck for ADHD

Scientists at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health report the first evidence that prenatal exposure to polycyclic aromatic hydrocarbons (PAH)—carcinogenic ...

Cardiology

MRI measures can predict pulmonary arterial HTN outcome

(HealthDay)—Magnetic resonance imaging (MRI) measures can predict outcomes in pulmonary arterial hypertension (PAH), according to a study published online March 22 in the American Journal of Respiratory and Critical Care ...

Diseases, Conditions, Syndromes

Breakthrough could help sufferers of fatal lung disease

Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients suffering from the fatal lung disease pulmonary arterial hypertension (PAH).

page 4 from 7